ref | title | DOI | material type | comment |
---|---|---|---|---|
172 | Integration of Fe3O4 with Bi2S3 for Multi-Modality Tumor Theranostics | https://doi.org/10.1021/acsami.0c05088 | Composite | Fe3O4@PDA@BSA-Bi2S3 |
ref | material | size | size err | size unit | size type | size comment | BET | b nanozyme | b 10n | b unit | specific act | sa 10n | sa unit | comment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
172 | Fe3O4@PDA@BSA-Bi2S3 | 120, 125, and 123 | nm | DLS | The DLS size of Fe3O4@PDA@BSA-Bi2S3 NPs were indicated as 120, 125, and 123 nm, respectively, and showed no detectable fluctuation during the 5 days storage |
ref | material | enzyme type | substrate | pH | T | km | km err | km 10n | km unit | vmax | vmax err | vmax 10n | vmax unit | kcat | kcat err | kcat 10n | kcat unit | kcat/km | kcat/km
10n | kcat/km unit | comment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
172 | Fe3O4@PDA@BSA-Bi2S3 | POD | H2O2 | 67.04 | mM | 2.2 | -8 | M/s | 172 |
ref | material | application | target | method | linear range | linear ran unit | LOD | lod unit | recovery | comment |
---|---|---|---|---|---|---|---|---|---|---|
172 | Fe3O4@PDA@BSA-Bi2S3 | a Fe3O4@PDA@BSA-Bi2S3 composite theranostic agent was successfully prepared for synergistic tumor PTT and CDT, in which the BSA coating endows the NPs with colloidal stability and both in vitro and in vivo biocompatibility. |